BINVBrandes International ETF
Seeks long-term capital appreciation through investments in foreign equity securities.
By Brandes · Launched 2023
Annual Cost
0.70%
#3,529 of 5,562 · average
Fund Size
$490M
#1,582 of 5,562 · large
Return (1Y)Goal
+22.7%
Track Record
2 years
#3,223 of 5,562 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$12,295+22.9%
Total-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 24.0% of fund✓ well diversified
Sanofi SA
2.7%
Alibaba Group Holding Ltd
2.7%
Takeda Pharmaceutical Co Ltd
2.6%
GSK PLC
2.5%
PETROBRAS
2.4%
Kering SA
2.3%
Astellas Pharma Inc
2.2%
STMicroelectronics NV
2.2%
Heineken Holding NV
2.2%
Carrefour SA
2.1%
Asset allocation
Stocks
98.4%
Cash
1.6%
By sector
Consumer Defensive
23.1%
Healthcare
17.1%
Consumer Cyclical
15.1%
Industrials
11.0%
Technology
9.1%
Financial Services
7.9%
Communication
6.2%
Basic Materials
5.0%
Other
5.5%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
14.0%Moderate
Year-on-year price swings
Max drawdown
-14.9%Mild
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Where to buy
Listing
- Exchange
- Cboe BZX
Full fund details
- Objective
- Seeks long-term capital appreciation through investments in foreign equity securities.
- Strategy
- Actively managed, invests primarily in common and preferred stocks, ADRs, and warrants of foreign companies with market caps over $5 billion. Focuses on value investing principles, selecting undervalued securities for long-term growth, with potential exposure to emerging markets.
- Inception date
- October 3, 2023
- Fund family
- Brandes
Similar ETFs
Closest matches by profileWhat's next?
You've reviewed BINV. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19